Iseki Takamoto

6.4k total citations
31 papers, 1.7k citations indexed

About

Iseki Takamoto is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Iseki Takamoto has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Molecular Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Iseki Takamoto's work include Pancreatic function and diabetes (14 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Metabolism, Diabetes, and Cancer (8 papers). Iseki Takamoto is often cited by papers focused on Pancreatic function and diabetes (14 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Metabolism, Diabetes, and Cancer (8 papers). Iseki Takamoto collaborates with scholars based in Japan, India and United Kingdom. Iseki Takamoto's co-authors include Takashi Kadowaki, Naoto Kubota, Kohjiro Ueki, Tetsuya Kubota, Yasuo Terauchi, Toshimasa Yamauchi, Masao Moroi, Tetsuo Noda, Wataru Yano and Kazuyuki Tobe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Iseki Takamoto

31 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iseki Takamoto Japan 20 738 595 518 490 429 31 1.7k
David Vicent Spain 19 899 1.2× 340 0.6× 535 1.0× 331 0.7× 461 1.1× 37 2.0k
Daniel Giannella‐Neto Brazil 24 526 0.7× 394 0.7× 376 0.7× 397 0.8× 736 1.7× 71 1.8k
Atsuko Nakatsuka Japan 20 662 0.9× 757 1.3× 574 1.1× 390 0.8× 448 1.0× 50 2.2k
Mengliu Yang China 30 933 1.3× 802 1.3× 767 1.5× 380 0.8× 488 1.1× 94 2.5k
Maria Lúcia Corrêa‐Giannella Brazil 27 528 0.7× 417 0.7× 298 0.6× 405 0.8× 580 1.4× 122 1.9k
Mikkel Holm Vendelbo Denmark 30 969 1.3× 344 0.6× 984 1.9× 299 0.6× 426 1.0× 93 2.5k
Birgit Knebel Germany 25 838 1.1× 502 0.8× 445 0.9× 339 0.7× 353 0.8× 84 1.7k
Yasumichi Mori Japan 18 901 1.2× 303 0.5× 485 0.9× 404 0.8× 584 1.4× 50 1.8k
Nassim Dali‐Youcef France 18 659 0.9× 332 0.6× 492 0.9× 262 0.5× 229 0.5× 37 1.8k
Kazuyuki Hida Japan 20 516 0.7× 700 1.2× 487 0.9× 183 0.4× 277 0.6× 37 1.8k

Countries citing papers authored by Iseki Takamoto

Since Specialization
Citations

This map shows the geographic impact of Iseki Takamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iseki Takamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iseki Takamoto more than expected).

Fields of papers citing papers by Iseki Takamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iseki Takamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iseki Takamoto. The network helps show where Iseki Takamoto may publish in the future.

Co-authorship network of co-authors of Iseki Takamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Iseki Takamoto. A scholar is included among the top collaborators of Iseki Takamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iseki Takamoto. Iseki Takamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Takanori, Tetsuya Kubota, Mariko Inoue, et al.. (2021). Lack of Brain Insulin Receptor Substrate-1 Causes Growth Retardation, With Decreased Expression of Growth Hormone–Releasing Hormone in the Hypothalamus. Diabetes. 70(8). 1640–1653. 4 indexed citations
2.
Fujiwara, Takeo, Iseki Takamoto, Airi Amemiya, et al.. (2017). Is a hilly neighborhood environment associated with diabetes mellitus among older people? Results from the JAGES 2010 study. Social Science & Medicine. 182. 45–51. 34 indexed citations
3.
Sakurai, Yoshitaka, Naoto Kubota, Iseki Takamoto, et al.. (2017). Role of insulin receptor substrates in the progression of hepatocellular carcinoma. Scientific Reports. 7(1). 5387–5387. 37 indexed citations
4.
Kubota, Naoto, Tetsuya Kubota, Tomokatsu Iwamura, et al.. (2016). Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity. Nature Communications. 7(1). 12977–12977. 93 indexed citations
5.
Kubota, Tetsuya, Naoto Kubota, Hiroyuki Satō, et al.. (2016). Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways. Scientific Reports. 6(1). 34707–34707. 9 indexed citations
6.
Satō, Hiroyuki, Naoto Kubota, Tetsuya Kubota, et al.. (2016). Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice. Diabetologia. 59(11). 2426–2434. 18 indexed citations
7.
Masamoto, Yosuke, Shunya Arai, Tomohiko Sato, et al.. (2016). Adiponectin Enhances Antibacterial Activity of Hematopoietic Cells by Suppressing Bone Marrow Inflammation. Immunity. 44(6). 1422–1433. 44 indexed citations
8.
Hashimoto, Shinji, Naoto Kubota, Hiroyuki Satō, et al.. (2014). Insulin Receptor Substrate-2 (Irs2) in Endothelial Cells Plays a Crucial Role in Insulin Secretion. Diabetes. 64(3). 876–886. 35 indexed citations
9.
Kubota, Naoto, Iseki Takamoto, Tetsuya Kubota, et al.. (2013). Dipeptidyl peptidase-4 inhibitor anagliptin ameliorates diabetes in mice with haploinsufficiency of glucokinase on a high-fat diet. Metabolism. 62(7). 939–951. 11 indexed citations
10.
Takamoto, Iseki, Naoto Kubota, Katsuyoshi Kumagai, et al.. (2013). TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass. Diabetologia. 57(3). 542–553. 73 indexed citations
11.
Awazawa, Motoharu, Kohjiro Ueki, Kazunori Inabe, et al.. (2011). Adiponectin Enhances Insulin Sensitivity by Increasing Hepatic IRS-2 Expression via a Macrophage-Derived IL-6-Dependent Pathway. Cell Metabolism. 13(4). 401–412. 228 indexed citations
12.
Mutoh, Michihiro, Shinji Takasu, Mami Takahashi, et al.. (2011). Loss of Adiponectin Promotes Intestinal Carcinogenesis in Min and Wild-type Mice. Gastroenterology. 140(7). 2000–2008.e2. 62 indexed citations
13.
Takamoto, Iseki & Takashi Kadowaki. (2010). [New diagnostic criteria of diabetes mellitus in Japan, 2010].. PubMed. 68 Suppl 9. 26–31. 1 indexed citations
14.
Yano, Wataru, Naoto Kubota, Shinsuke Itoh, et al.. (2008). Molecular Mechanism of Moderate Insulin Resistance in Adiponectin-Knockout Mice. Endocrine Journal. 55(3). 515–522. 48 indexed citations
15.
Watanabe, Taku, Naoto Kubota, Mitsuru Ohsugi, et al.. (2008). Rimonabant Ameliorates Insulin Resistance via both Adiponectin-dependent and Adiponectin-independent Pathways. Journal of Biological Chemistry. 284(3). 1803–1812. 40 indexed citations
16.
Kubota, Naoto, Yasuo Terauchi, Tetsuya Kubota, et al.. (2006). Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and -independent Pathways. Journal of Biological Chemistry. 281(13). 8748–8755. 269 indexed citations
17.
Kubota, Naoto, Yasuo Terauchi, Kazuyuki Tobe, et al.. (2004). Insulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus. Journal of Clinical Investigation. 114(7). 917–927. 189 indexed citations
18.
Takamoto, Iseki & Takashi Kadowaki. (2004). [Diabetes and osteoporosis].. PubMed. 14(2). 255–61. 9 indexed citations
19.
Kubota, Naoto, Yasuo Terauchi, Kazuyuki Tobe, et al.. (2004). Insulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus. Journal of Clinical Investigation. 114(7). 917–927. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Vicent Breakdown of academic impact, for papers by Daniel Giannella‐Neto Breakdown of academic impact, for papers by Atsuko Nakatsuka Breakdown of academic impact, for papers by Mengliu Yang Breakdown of academic impact, for papers by Maria Lúcia Corrêa‐Giannella Breakdown of academic impact, for papers by Mikkel Holm Vendelbo Breakdown of academic impact, for papers by Birgit Knebel Breakdown of academic impact, for papers by Yasumichi Mori Breakdown of academic impact, for papers by Nassim Dali‐Youcef Breakdown of academic impact, for papers by Kazuyuki Hida
Rankless by CCL
2026